Home › Funds › Finepoint Capital LP › CLDI

Finepoint Capital LP position in CLDI

CALIDI BIOTHERAPEUTICS INC · Health Care

Finepoint Capital LP reported holding 66 shares of CLDI (CALIDI BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$0K, representing 0.00% of its reported portfolio and ranking #10 among its reported holdings. Finepoint Capital LP has disclosed CLDI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)66 sh
Reported value held$71
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Finepoint Capital LP's CLDI position evolved

Finepoint Capital LP first disclosed a stake in CLDI in Q3 2023 at 125,000 shares (US$416K). Across 13 filings, Finepoint Capital LP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 66 shares valued at US$0K — a reduction of -976 shares quarter over quarter.. Notable position changes include a 90% trim in Q3 2024 (shares were roughly flat over the following quarter), a 92% trim in Q3 2025 (shares fell 23% over the following quarter), a 94% trim in Q3 2026 (shares fell 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 125.00K $415.62K New
Q4 2023 125.00K $188.75K Hold
Q1 2024 125.00K $70.62K Hold
Q2 2024 125.00K $25.00K Hold
Q3 2024 12.50K $14.25K Reduce
Q4 2024 12.50K $14.38K Hold
Q1 2025 12.50K $7.08K Hold
Q2 2025 12.50K $2.88K Hold
Q3 2025 1.04K $1.58K Reduce
Q4 2025 1.04K $1.22K Hold
Q1 2026 1.04K $249 Hold
Q2 2026 1.04K $177 Hold
Q3 2026 66 $71 Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDI and 13F data

CLDI (CALIDI BIOTHERAPEUTICS INC) is a Health Care company. 14 other funds we track also report a position in CLDI. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDI

No other tracked fund reports a position in CLDI.

All CLDI fund holders →

FAQ

How long has Finepoint Capital LP held CLDI?

Finepoint Capital LP has disclosed CLDI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Finepoint Capital LP's current position in CLDI?

As of Q3 2026, Finepoint Capital LP holds 66 shares of CLDI (CALIDI BIOTHERAPEUTICS INC), valued at $71, representing 0.00% of its reported portfolio and ranking #10.

Has Finepoint Capital LP been buying or selling CLDI?

In the latest 13F filing (Q3 2026), Finepoint Capital LP reduced its position in CLDI.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.